The CHIVA study: a GINECO randomized double blind phase II trial of nintedanib versus placebo with the neo-adjuvant chemotherapy (NACT) strategy for patients (pts) with advanced unresectable ovarian cancer (OC). Report of the interval debulking surgery (I

Affiliation auteursAffiliation ok
TitreThe CHIVA study: a GINECO randomized double blind phase II trial of nintedanib versus placebo with the neo-adjuvant chemotherapy (NACT) strategy for patients (pts) with advanced unresectable ovarian cancer (OC). Report of the interval debulking surgery (I
Type de publicationJournal Article
Year of Publication2016
AuteursFerron G., De Rauglaudre G., Ray-Coquard I.L, Lesoin A., Joly F., Lortholary A., Raban N., Peron J., Malaurie-Agostini E., Gouy S., Kaminsky M-C., Meunier J., Alexandre J., Berton-Rigaud D., Coussy F., Favier L., Venat-Bouvet L., Marmion F., Combe P., Pujade-Lauraine E.
JournalANNALS OF ONCOLOGY
Volume27
Date PublishedOCT 1
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1093/annonc/mdw374.6